Skip to content
POM-V Prescription Required Companion Animal

Rycarfa 50 mg Tablets for Dogs

Active ingredient: Carprofen

Form

Tablet

Species

Dogs

Manufacturer

KRKA, d.d., Novo mesto

VMD MA No.

01656/4070

What it's used for

of post-operative pain.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Carprofen

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Rycarfa 50 mg Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

of post-operative pain.
2 to 4 mg carprofen per kg bodyweight per day.
An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily
dose or in two equally divided doses may, subject to clinical response, be reduced
after 7 days to 2 mg carprofen/kg bodyweight/day given as a single dose.
In order to adjust the dosage, the tablets can be divided into two equal parts.
Duration of treatment will be dependent upon the response seen. Long term
treatment should be under regular veterinary supervision.
To extend analgesic and anti-inflammatory cover post-operatively, parenteral
preoperative treatment may be followed with Carprofen tablets at 4 mg/kg/day for up
to 5 days.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
Do not use in cats.
Do not use in pregnant or lactating bitches.
Do not use in dogs less than 4 months of age.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
AN: 03934/2024 and 03937/2024Page 2 of 5
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a
possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a
blood dyscrasia.
Dogs:
Rare
(1 to 10 animals / 10 000
animals treated):
Renal disorder.
Hepatic disorder
.
Undetermined frequency
(cannot be estimated from the
available data):
Vomiting
, loose stool
, diarrhoea
, blood in
faeces
, appetite loss
, lethargy
.
Idiosyncratic reaction.
Transient. Generally, occur within the first treatment week and in most cases
disappear following termination of the treatment but in very rare cases may be
serious or fatal.
If adverse reactions occur, use of the veterinary medicinal product should be stopped
and the advice of a veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
AN: 03934/2024 and 03937/2024Page 3 of 5
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
Refer to Sections 3.3 and

Special precautions for safe use in the target species:
Use in aged dogs may involve additional risk.
If such a use cannot be avoided, dogs may require careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a
potential risk of increased renal toxicity.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment of
inflammatory conditions associated with bacterial infection, appropriate concurrent
antimicrobial therapy should be instigated.
See section 3.8.
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out
of reach of the animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician. Wash hands after handling the product.
Special precautions for the protection of the environment:
Not applicable.
Do not administer other NSAIDs and glucocorticoids concurrently or within 24 hours
of administration of the product. Carprofen is highly bound to plasma proteins and
may compete with other highly bound drugs, which can lead to toxic effects.
Concurrent administration of potential nephrotoxic drugs should be avoided.
Store in the original package in order to protect from light and moisture.
AN: 03934/2024 and 03937/2024Page 5 of 5
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.